Literature DB >> 17933541

5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.

Loredana Cappellacci1, Palmarisa Franchetti, Patrizia Vita, Riccardo Petrelli, Antonio Lavecchia, Barbara Costa, Francesca Spinetti, Claudia Martini, Karl-Norbert Klotz, Mario Grifantini.   

Abstract

A series of 5'-carbamoyl and 5'-thionocarbamoyl derivatives of 2'-C-methyl analogues of the A(1) adenosine receptor (A(1)AR) full agonists N(6)-cyclopentyladenosine (CPA), 2-chloro-N(6)-cyclopentyladenosine (CCPA), N(6)-[3-(R)-tetrahydrofuranyl]adenosine (tecadenoson), and 2-chloro analogue (2-Cl-tecadenoson) was synthesized and evaluated for their affinity for adenosine receptor subtypes from bovine, porcine, and human species. In the N(6)-cyclopentylamino series, the 5'-substituted derivatives showed a reduced affinity at the bovine A(1)AR compared to the parent compounds; however, the selectivity for A(1) versus A(2A) receptor was retained or increased. The corresponding N(6)-3-(R)-tetrahydrofuranylamino analogues displayed a very low affinity toward the bovine A(1)AR. The 5'-methylthionocarbamoyl derivative of 2'-Me-CCPA showed the best affinity at porcine A(1)AR with a K(i) value of 13 nM. At human AR subtypes tecadenoson derivatives showed 2.3- to 5-fold lower affinity at A(1)AR and very low affinity at the other subtypes (A(2A), A(2B), and A(3)) compared to the corresponding N(6)-cyclopentyl analogues. The 5'-carbamoyl and 5'-thionocarbamoyl derivatives of 2'-Me-CCPA 3, 4, 7 and tecadenoson derivative 12 were found to be partial A(1) agonists at the porcine receptor. Docking studies explained the lower affinity of N(6)-3-(R)-tetrahydrofuranyl-substituted compounds at bovine A(1)AR compared to that of N(6)-cyclopentyl analogues, showing that the oxygen of the tetrahydrofuranyl ring establishes unfavorable electrostatic interactions with the CO oxygen of Asn254. The low binding affinity of the 2'-C-methyl-N(6)-3-(R)-tetrahydrofuranyl adenosine analogues at human A(1)AR may be ascribed to the presence of unfavorable interactions between the hydrophilic tetrahydrofuranyl ring and the surrounding hydrophobic residues Leu250 (TM6) and Ile274 (TM7).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17933541     DOI: 10.1016/j.bmc.2007.09.035

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.

Authors:  Ilia Korboukh; Emily A Hull-Ryde; Joseph E Rittiner; Amarjit S Randhawa; Jennifer Coleman; Brendan J Fitzpatrick; Vincent Setola; William P Janzen; Stephen V Frye; Mark J Zylka; Jian Jin
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

2.  Azide-tetrazole equilibrium of C-6 azidopurine nucleosides and their ligation reactions with alkynes.

Authors:  Mahesh K Lakshman; Manish K Singh; Damon Parrish; Raghavan Balachandran; Billy W Day
Journal:  J Org Chem       Date:  2010-04-16       Impact factor: 4.354

3.  Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors.

Authors:  Matthew R Bockman; Alvin S Kalinda; Riccardo Petrelli; Teresa De la Mora-Rey; Divya Tiwari; Feng Liu; Surrendra Dawadi; Madhumitha Nandakumar; Kyu Y Rhee; Dirk Schnappinger; Barry C Finzel; Courtney C Aldrich
Journal:  J Med Chem       Date:  2015-09-03       Impact factor: 7.446

4.  AMP is an adenosine A1 receptor agonist.

Authors:  Joseph E Rittiner; Ilia Korboukh; Emily A Hull-Ryde; Jian Jin; William P Janzen; Stephen V Frye; Mark J Zylka
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

5.  Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.

Authors:  Leo M Gazoni; Dustin M Walters; Eric B Unger; Joel Linden; Irving L Kron; Victor E Laubach
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-15       Impact factor: 5.209

6.  The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages.

Authors:  A Buenestado; S Grassin Delyle; I Arnould; F Besnard; E Naline; S Blouquit-Laye; A Chapelier; J F Bellamy; P Devillier
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

7.  Synthesis of N6 ,N6-Dialkyl Adenine Nucleosides With In Situ Formed Hexaalkylphosphorus Triamides.

Authors:  Mahesh K Lakshman; Asad Choudhury; Suyeal Bae; Eliezer Rochttis; Padmanava Pradhan; Amit Kumar
Journal:  European J Org Chem       Date:  2009-01-01

Review 8.  Animal models of airway diseases.

Authors:  Linda F Thompson; Maryse Picher; Michael R Blackburn
Journal:  Subcell Biochem       Date:  2011

Review 9.  Adenosine receptors as promising targets for the management of ocular diseases.

Authors:  Eleonora Spinozzi; Cecilia Baldassarri; Laura Acquaticci; Fabio Del Bello; Mario Grifantini; Loredana Cappellacci; Petrelli Riccardo
Journal:  Med Chem Res       Date:  2021-01-25       Impact factor: 2.351

10.  5'-Chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A(1) receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions.

Authors:  Livio Luongo; Riccardo Petrelli; Luisa Gatta; Catia Giordano; Francesca Guida; Patrizia Vita; Palmarisa Franchetti; Mario Grifantini; Vito de Novellis; Loredana Cappellacci; Sabatino Maione
Journal:  Molecules       Date:  2012-11-22       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.